Anpoly

BiopolymersSeries BPohang, South Koreaanpolyinc.com

Latest round

Series B

Last raised

Aug 2022

Total raised

$13M

Investors

8

About Anpoly

a. Anpoly operates as a biopolymer material manufacturer that develops new materials from discarded waste that can replace petrochemical-based plastics and various synthetic polymers through technologies, such as original material development technology, material application technology, and green process technology. As of August 2022, Street Iron is the CEO of the company. Ayenpoli provides nanocellulose like polycellu T-CNF hydrogel, polycellu T-CNF powder, and CNC (cellulose nanocrystal), which are biopolymer materials with a tensile elastic modulus similar to Kevlar used across lightweight composites, packaging materials, filtration, cosmetics, and medical biomaterials. The company also offers polychito nanochitin hydrogel, a non-toxic, biodegradable, and biocompatible biopolymer used in biomedical applications, including tissue supports, drug delivery, and wound dressing.

Who invested in Anpoly

8 investors across 5 rounds

See all investors in Anpoly

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Aug 15, 2022

    Amount

    $8.1M

    Investors

    Locked

  2. Series A

    Jun 29, 2021

    Amount

    $1.3M

    Investors

    Locked

  3. Series A

    Oct 28, 2020

    Amount

    $1.8M

    Investors

    Locked

  4. Series A

    Apr 19, 2020

    Amount

    $1.6M

    Investors

    Locked

  5. Seed

    May 1, 2019

    Amount

    Undisclosed

    Investors

    Locked

Questions about Anpoly

Who invested in Anpoly?

Anpoly has 8 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Anpoly raised?

Anpoly has raised 5 venture rounds. Sign up free to see how much each round raised and the total.

When did Anpoly last raise money?

Anpoly's most recent round on record is a Series B, in Aug 2022.

What does Anpoly do?

Anpoly is a biopolymers company.

Where is Anpoly headquartered?

Anpoly is headquartered in Pohang, South Korea.

Which VCs invest in companies like Anpoly?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biopolymers companies at Anpoly's stage. Their profiles are linked below.

Raising like Anpoly? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.